Nutraceutical innovator DolCas Biotech, LLC, has successfully infused beneficial marine collagen tripeptides into a chocolate bar. Each square (about 8g) contains 1g of Morikol®, an ultra-low-molecular weight of fish collagen tripeptide with clinically validated effectiveness at this uniquely minimal dose.
Merging wellness with indulgence, Morikol breaks into the flourishing functional foods arena by demonstrating its stellar capabilities to seamlessly integrate concentrated collagen into milk, dark, or white chocolate without affecting the comforting flavor, aroma, or texture of these popular confections.
Morikol is a next-generation, Type I & III fish collagen tripeptide that offers high bioavailability and rapid absorption due to its exceptionally low molecular weight and unique structure. Morikol boasts an abundant content of functional three-amino-acid sequenced tripeptides composed of glycine, proline, and hydroxyproline. These structures, known as “GPH,” have been shown to stimulate collagen generation, as well as the synthesis of the hyaluronic acid and ceramides enzymes essential for maintaining the skin barrier and cell membrane structure.
Less is More
“Most collagen ingredients come in 5g-10g doses,” explains K. G. Rao, founder and CEO of DolCas Biotech. “Morikol‘s low concentration of the bioactive component makes it ideal for innovative delivery formats. One square of chocolate can now deliver a full clinical dose of collagen peptides, whether for beauty-from-within or joint comfort, and still satisfy the most discerning chocolate lover’s palate. Our ‘less is more’ collagen concept is transforming how people experience wellness by bringing a touch of sensory joy to the routine of supplementing with collagen.”
DolCas’ Morikol fish collagen is a fine concentrated powder that is odorless, neutral in flavor, and highly soluble. This advancement breaks away from the conventional and often inconvenient need for bulky collagen powders, offering consumers a delicious and indulgent alternative to capsules or pills in alignment with modern preferences.
“This is the only fish collagen clinically studied to deliver measurable benefits for skin health at a daily 1g dose, or for joint mobility at a 2g daily dose,” affirms Rao.
In one clinical trial conducted on 53 women volunteers, a daily intake of 1g Morikol over a period of 12 weeks resulted in substantial improvements in skin elasticity and dermal hydration, and elicited visible skin benefits as along with protection from sun-induced aging. Overall, the group taking Morikol showed a 10.5-fold greater improvement in wrinkle visual scores compared to the placebo group at 12 weeks. These benefits were already beginning to show after six weeks of intake, particularly around the cheeks and crow’s feet.
In another 10-week clinical study conducted on 64 participants complaining of mild knee pain, a 2g daily dose of Morikol reduced fluid build-up around the joints, as well as mitigated cracking and pain.
Previous lab and animal assessments have demonstrated the direct uptake of Morikol’s tripeptides across the intestinal barrier and into the bloodstream intact through PEPT1 transporters owed to its unique hydrolyzed enzyme formulation. These tripeptides have been shown to increase mRNA expression of collagen production in a cell study.
“Morikol’s piscine tripeptides are designed to reach vulnerable and damaged sites of the skin, bone, and tendons where it activates osteoblasts and fibroblasts, in turn helping promote collagen synthesis, boosting bone and connective tissue integrity as well as keeping joints lubricated,” Rao elaborates.
Read more latest industry news and developments in our free to download magazine.
Never miss a story… Follow us on:
LinkedIn: International Confectionery
YouTube: @ConfectioneryTV
Media contact
Joseph Clarke
Editor, International Confectionery
Tel: +44 (0) 1622 823 920
Email: [email protected]
